WallStSmart

Alkami Technology Inc (ALKT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Alkami Technology Inc generates 71% more annual revenue ($443.64M vs $258.90M). ALKT leads profitability with a -10.7% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

ALKT

Hold

36

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 6.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALKTUndervalued (+46.1%)

Margin of Safety

+46.1%

Fair Value

$31.27

Current Price

$16.42

$14.85 discount

UndervaluedFair: $31.27Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALKT1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
34.7%10/10

Revenue surging 34.7% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

ALKT4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.76B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-13.3%2/10

ROE of -13.3% — below average capital efficiency

Profit MarginProfitability
-10.7%1/10

Currently unprofitable

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : ALKT

The strongest argument for ALKT centers on Revenue Growth. Revenue growth of 34.7% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : ALKT

The primary concerns for ALKT are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 36/100) and 43.0% revenue growth. ALKT offers better value entry with a 46.1% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alkami Technology Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Alkami Technology, Inc. offers a cloud-based digital banking platform to serve banks and credit unions in the United States. The company is headquartered in Plano, Texas.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?